Otsuka jumps into the US biotech M&A game, bagging Visterra in $430M buyout
After raising a bit more than $117 million from some blue chip backers like the Bill & Melinda Gates Foundation, Vertex and Flagship, Waltham, MA …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
